Basilea Pharmceutica NA buy Quitte
Start price
21.04.16
/
50%
€75.33
Target price
21.10.16
€79.00
Performance (%)
-13.13%
End price
21.10.16
€65.44
Summary
This prediction ended on 21.10.16 with a price of €65.44. The price of Basilea Pharmceutica NA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.13%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Basilea Pharmceutica NA | - | - | - | - |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % | 46,26 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % | 72,33 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % | 52,28 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % | 55,10 % |
Comments by Quitte for this prediction
In the thread Basilea Pharmceutica NA diskutieren
Kampf gegen Hirntumor
Basilea berichtet über Präsentation von Daten zu den klinischen Onkologie-Kandidaten BAL101553 und BAL3833 auf AACR-Tagung
(Laufzeit überschritten)